Table 2.
Immunohistochemical labeling results of liver tissues
| Tissue type | Labeling for | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELF | TBRII | Smad4 | |||||||||||||
| + + | + | − | NA | P | + + | + | − | NA | P | + + | + | − | NA | P | |
| Normal | 10 | 0 | 0 | − | 0.026* | 3 | 0 | 0 | 6 | NS | 1 | 2 | 0 | 7 | NS |
| Carcinoma | 1 | 3 | 5 | − | 0.017* | 5 | 3 | 1 | − | NS | 0 | 3 | 2 | 4 | NS |
Abbreviations: ELF, embryonic liver fodrin; NA, not available; TBRII, transforming growth factor-β receptor type II. Data obtained were statistically significant at P < 0.05. For ELF, + +, >70% nuclear labeling; +, 15–70% nuclear labeling; −, <15% nuclear labeling; for TBRII and Smad4, + +, intense labeling; +, moderate labeling; −, loss of or reduced labeling.
*
Statistically significant.